This script search US Code. View Rule
Menu Item - Home
Menu Item - Agenda Main page
Menu Item - Historical Agenda
Menu Item - Historical Agenda
Menu Item - Agenda Search
Menu Item - EO Dashboard
Menu Item - Reg Review
Menu Item - EO Agency lists
Menu Item - EO Search
Menu Item - EO Historical Reports
Menu Item - Review Counts
Menu Item - OIRA Letters
Menu Item - EOM 12866 Search
Menu Item - EO XML Reports
Menu Item - ICR Dashboard page
Menu Item - ICR Main page
Menu Item - ICR Search
Menu Item - ICR XML Reports
Menu Item - FAQ
Menu Item - Additional Resources
Menu Item - Contact Us
Search: Agenda Reg Review ICR
       Search

View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML

HHS/FDA RIN: 0910-AC50 Publication ID: Spring 2003 
Title: ●Food Labeling: Trans Fatty Acids in Nutrition Labeling: Consumer Research To Consider Possible Footnote Statements 
Abstract: This advance notice of proposed rulemaking (ANPRM) is intended to publish in the same issue of the Federal Register as the trans fat final rule that would require that the quantitative amount of trans fat be declared in the nutrition label of conventional foods and dietary supplements on a separate line immediately under the line for saturated fat. This ANPRM would solicit information and data on whether to consider footnote statements for possible use in the nutrition label about trans fat, either alone or in combination with saturated fat and cholesterol, to enhance consumers' understanding about such fat in foods and how to use the information to make healthy food choices. FDA is soliciting information and data on language in any such statements and the impact on consumers from such statements. Information obtained from this solicitation and that resulting from consumer studies conducted by FDA may be used to help draft a proposed rule that would require the use of a footnote in the Nutrition Facts panel about one or more of the cholesterol-raising lipids to increase consumer understanding of the relative significance of these lipids in foods. 
Agency: Department of Health and Human Services(HHS)  Priority: Other Significant 
RIN Status: First time published in the Unified Agenda Agenda Stage of Rulemaking: Prerule Stage 
Major: No  Unfunded Mandates: No 
CFR Citation: 21 CFR 101 
Legal Authority: 21 USC 321; 21 USC 343; 21 USC 371 
Legal Deadline:  None
Timetable:
Action Date FR Cite
ANPRM  06/00/2003   
Regulatory Flexibility Analysis Required: No  Government Levels Affected: Federal 
Federalism: No 
Included in the Regulatory Plan: No 
Related RINs: Related to 0910-AB66 
Agency Contact:
Julie Moss
Consumer Safety Officer
Department of Health and Human Services
Food and Drug Administration
(HFS-832), Center for Food Safety and Applied Nutrition (HFS-830), 5100 Paint Branch Parkway,
College Park, MD 20740
Phone:301 436-2373
Fax:301 436-2639
Email: julie.moss@fda.hhs.gov

 
About Us   Vertical Spacer Spacer Related Resources   Vertical Spacer Spacer Disclosure   Vertical Spacer Spacer Accessibility   Vertical Spacer Spacer Privacy Policy   Vertical Spacer Spacer Contact Us